Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck

Conditions:   Salivary Gland Carcinoma;   Metastatic Cancer;   Recurrent Cancer
Intervention:   Drug: Nivolumab
Sponsor:   UNICANCER
Recruiting - verified April 2017

http://ift.tt/2oBdDee